Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.71 |
| ▸ | MEN1 | O00255 | 5/20 | 0.71 |
| ▸ | PGR | P06401 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | GSK3B | P49841 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1446261 | 1.00 | KMT2A (0.71) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL10672193 | 0.89 | KMT2A (0.70) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL10673281 | 0.88 | MEN1 (0.65) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL10671563 | 0.86 | KMT2A (0.65) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL4507476 | 0.86 | MEN1 (0.53) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL7612454 | 0.84 | MEN1 (0.52) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL15190559 | 0.84 | MEN1 (0.51) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL8144841 | 0.84 | MEN1 (0.51) | KMT2AMEN1PGRALDH1A1KDM4E | |
| Paquinimod SCHEMBL1573633 | 0.83 | MEN1 (0.50) | KMT2AMEN1PGRALDH1A1KDM4E | |
| SCHEMBL5164257 | 0.83 | MEN1 (0.50) | KMT2AMEN1PGRALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114845718-B | Compounds for the treatment of ocular diseases associated with excessive angiogenesis | 活跃生物技术有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-114845718-A | Compounds for the treatment of ocular diseases associated with excessive vascularization | 活跃生物技术有限公司 | 2022-08-02 | — | — | CN | disclosed |